Investing
Bristol Myers wins dismissal of lawsuit over Celgene drugs
![](https://personalfinancedefined.com/wp-content/uploads/2023/02/LYNXNPEB8506G_L.jpg)
© Reuters. FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder
NEW YORK (Reuters) – A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers (NYSE:) Squibb Co of defrauding investors who stood to receive $6.4 billion had it won federal approval by specified deadlines for drugs developed by the former Celgene Corp (NASDAQ:).
Read the full article here
![](https://personalfinancedefined.com/wp-content/uploads/2023/02/pf-logo.png)
-
Personal Finance6 days ago
Gas prices drop as demand for driving fizzles out: AAA
-
Investing6 days ago
Crowdstrike CEO Responds to Causing Largest IT Outage in History
-
Side Hustles6 days ago
How to Build A Startup, From an Early Lyft, Twitch Investor
-
Passive Income6 days ago
The Top 5 AI Tools That Can Revolutionize Your Workflow and Boost Productivity
-
Passive Income4 days ago
NLRB Drops Expanded Joint Employer Appeal
-
Side Hustles6 days ago
Jake Paul: Mindset Hacks, Mike Tyson Fight, Embracing Fear
-
Investing6 days ago
Boeing to supply E-7 in first major win since plea deal By Reuters
-
Side Hustles5 days ago
10 Effective Growth Marketing Strategies for Your Startup